Nuvalent (NUVL) director Oliger awarded 3,444 RSUs, total holdings 7,415 shares

Rhea-AI Filing Summary

Oliger Christy J. reported acquisition or exercise transactions in this Form 4 filing.

Nuvalent, Inc. director Christy J. Oliger reported a compensation-related equity award of 3,444 shares of Class A Common Stock in the form of restricted stock units (RSUs). These RSUs vest in full on the earlier of June 16, 2027 or Nuvalent’s next annual stockholder meeting, subject to continued service. Following this grant, Oliger reports 7,415 shares of Class A Common Stock, including these RSUs, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Oliger Christy J.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	3,444	$0.00	--

Holdings After Transaction: Class A Common Stock — 7,415 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 3,444 shares Reported holdings after transaction: 7,415 shares Grant price per share: $0.00 per share +1 more

4 metrics

RSU grant size 3,444 shares Class A Common Stock RSUs granted to director

Reported holdings after transaction 7,415 shares Total Class A Common Stock following RSU grant

Grant price per share $0.00 per share Non-cash equity award of RSUs

RSU vesting date June 16, 2027 Vests earlier of this date or next annual meeting

Key Terms

restricted stock units ("RSUs"), transaction code "A", Class A Common Stock, vesting

4 terms

restricted stock units ("RSUs") financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

transaction code "A" financial

"transaction_code_description": "Grant, award, or other acquisition""

Class A Common Stock financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vesting financial

"The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Oliger Christy J.

(Last) (First) (Middle)

C/O NUVALENT, INC.

ONE BROADWAY, 14TH FLOOR

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/16/2026		A		3,444(1)	A	$0.00	7,415	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

	/s/ Nathan N. McConarty, attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Nuvalent (NUVL) disclose in this Form 4?

Nuvalent director Christy J. Oliger reported receiving 3,444 Class A Common Stock RSUs as a grant. The award was recorded at a price of $0.00 per share and is classified as a grant, award, or other acquisition of equity-based compensation.

How many Nuvalent (NUVL) shares does Christy J. Oliger hold after this grant?

After the reported RSU grant, Christy J. Oliger holds 7,415 shares of Nuvalent Class A Common Stock directly. This total includes the 3,444 shares underlying the newly awarded restricted stock units disclosed in the Form 4 filing.

When do Christy J. Oliger’s Nuvalent (NUVL) RSUs vest?

The 3,444 RSUs granted to Christy J. Oliger vest in full on the earlier of June 16, 2027 or the date of Nuvalent’s next annual meeting of stockholders, provided she continues to serve the company through the applicable vesting date.

What does the transaction code “A” mean in this Nuvalent (NUVL) Form 4?

In this Form 4, transaction code “A” indicates a grant, award, or other acquisition of securities. For Christy J. Oliger, it reflects a non-cash award of 3,444 RSUs, rather than an open-market purchase or sale of Nuvalent Class A Common Stock.

Are Christy J. Oliger’s Nuvalent (NUVL) RSUs settled one-for-one in shares?

Each restricted stock unit reported for Christy J. Oliger represents the right to receive one share of Nuvalent Class A Common Stock. Upon vesting, each RSU converts into a single share, subject to the continued-service requirement described in the filing footnote.

Is this Nuvalent (NUVL) Form 4 transaction a market buy or sell?

The Form 4 reports a grant of 3,444 RSUs to Christy J. Oliger at $0.00 per share, not a market trade. It is categorized as a grant, award, or other acquisition of equity compensation, with no open-market buying or selling activity disclosed in this filing.